These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28159151)

  • 21. Thrombolysis in Real Time: Demonstration of Revascularization with Intravenous Thrombolysis Therapy in the CT Scanner.
    Tan J; Aysenne A; Singh V
    J Neuroimaging; 2017 Jan; 27(1):50-58. PubMed ID: 27653945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke.
    Rubiera M; Alvarez-Sabín J; Ribo M; Montaner J; Santamarina E; Arenillas JF; Huertas R; Delgado P; Purroy F; Molina CA
    Stroke; 2005 Jul; 36(7):1452-6. PubMed ID: 15947260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of bilateral hand frostbite using transcatheter arterial thrombolysis after papaverine infusion.
    Saemi AM; Johnson JM; Morris CS
    Cardiovasc Intervent Radiol; 2009 Nov; 32(6):1280-3. PubMed ID: 19449067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rescue localized intra-arterial thrombolysis for hyperacute MCA ischemic stroke patients after early non-responsive intravenous tissue plasminogen activator therapy.
    Kim DJ; Kim DI; Kim SH; Lee KY; Heo JH; Han SW
    Neuroradiology; 2005 Aug; 47(8):616-21. PubMed ID: 15983773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using Intra-arterial tPA for Severe Frostbite Cases. An Observational Comparative Retrospective Study.
    Al Yafi MN; Danino MA; Izadpanah A; Coeugniet E
    J Burn Care Res; 2019 Oct; 40(6):907-912. PubMed ID: 31284296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A controlled trial of a prostacyclin and rt-PA in the treatment of severe frostbite.
    Cauchy E; Cheguillaume B; Chetaille E
    N Engl J Med; 2011 Jan; 364(2):189-90. PubMed ID: 21226604
    [No Abstract]   [Full Text] [Related]  

  • 27. Staged escalation therapy in acute basilar artery occlusion: intravenous thrombolysis and on-demand consecutive endovascular mechanical thrombectomy: preliminary experience in 16 patients.
    Pfefferkorn T; Mayer TE; Opherk C; Peters N; Straube A; Pfister HW; Holtmannspötter M; Müller-Schunk S; Wiesmann M; Dichgans M
    Stroke; 2008 May; 39(5):1496-500. PubMed ID: 18323481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous administration of a GPIIb/IIIa receptor antagonist extends the therapeutic window of intra-arterial tenecteplase-tissue plasminogen activator in a rat stroke model.
    Zhang L; Zhang ZG; Zhang C; Zhang RL; Chopp M
    Stroke; 2004 Dec; 35(12):2890-5. PubMed ID: 15514182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator.
    Xian Y; Federspiel JJ; Grau-Sepulveda M; Hernandez AF; Schwamm LH; Bhatt DL; Smith EE; Reeves MJ; Thomas L; Webb L; Bettger JP; Laskowitz DT; Fonarow GC; Peterson ED
    JAMA Neurol; 2016 Jan; 73(1):50-9. PubMed ID: 26551916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Use of tPA in the Treatment of Frostbite: A Systematic Review.
    Hutchison RL; Miller HM; Michalke SK
    Hand (N Y); 2019 Jan; 14(1):13-18. PubMed ID: 30227720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bridging intravenous-intra-arterial rescue strategy increases recanalization and the likelihood of a good outcome in nonresponder intravenous tissue plasminogen activator-treated patients: a case-control study.
    Rubiera M; Ribo M; Pagola J; Coscojuela P; Rodriguez-Luna D; Maisterra O; Ibarra B; Piñeiro S; Meler P; Romero FJ; Alvarez-Sabin J; Molina CA
    Stroke; 2011 Apr; 42(4):993-7. PubMed ID: 21372307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonlocalized lower gastrointestinal bleeding: provocative bleeding studies with intraarterial tPA, heparin, and tolazoline.
    Ryan JM; Key SM; Dumbleton SA; Smith TP
    J Vasc Interv Radiol; 2001 Nov; 12(11):1273-7. PubMed ID: 11698625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gender Differences in Exclusion Criteria for Recombinant Tissue-Type Plasminogen Activator.
    Fredwall M; Sternberg S; Blackhurst D; Lee A; Leacock R; Nathaniel TI
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2569-2574. PubMed ID: 27618196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of antiplatelet pre-treatment on the risk of intracranial haemorrhage in acute ischaemic stroke after intravenous thrombolysis.
    Dorado L; Millán M; de la Ossa NP; Guerrero C; Gomis M; López-Cancio E; Ricciardi AC; Dávalos A
    Eur J Neurol; 2010 Feb; 17(2):301-6. PubMed ID: 19912320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of intravenous thrombolysis for ischemic stroke in patients treated with warfarin.
    Mazya MV; Lees KR; Markus R; Roine RO; Seet RC; Wahlgren N; Ahmed N;
    Ann Neurol; 2013 Aug; 74(2):266-74. PubMed ID: 23744571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute ischemic stroke: comparison of low-dose and standard-dose regimes of tissue plasminogen activator.
    Sharma VK; Kawnayn G; Sarkar N
    Expert Rev Neurother; 2013 Aug; 13(8):895-902. PubMed ID: 23965163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of early post-treatment single-photon emission computed tomography imaging to predict outcome in stroke patients treated with intravenous tissue plasminogen activator.
    Abumiya T; Katoh M; Moriwaki T; Yoshino M; Aoki T; Imamura H; Aida T; Scichinohe H; Nakayama N; Kazumata K; Houkin K
    J Stroke Cerebrovasc Dis; 2014; 23(5):896-901. PubMed ID: 24045082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis.
    Anaissie JE; Monlezun DJ; Siegler JE; Waring ED; Dowell LN; Samai AA; George AJ; Kimbrough T; Berthaud J; Martin-Schild S
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2603-2609. PubMed ID: 27476340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis.
    Skeik N; Gits CC; Ehrenwald E; Cragg AH
    Vasc Endovascular Surg; 2013 Oct; 47(7):519-23. PubMed ID: 23899656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.